Internal Medicine, Medical Oncology · Woodbridge, VA
NPI
1417164476
Since 2007
Specialty
Internal Medicine, Medical Oncology
Code 207RX0202X
Group practices
1
Medicare group memberships
Hospitals
2
Hospital affiliations
2280 Opitz Blvd Ste 340
Woodbridge, VA, 22191
Phone (703) 590-8300
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.3M
183,172 services
Medicare patients, 2024
475
Average age 76
Drug cost, 2024
$4.7M
1,686 prescriptions
Company payments, 2025
$5,211
From 59 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farn Chan was code J0881 (injection, darbepoetin alfa, 1 microgram (non-esrd use)), 19,600 times for 23 patients. In total Farn Chan billed 183,172 services in 111 codes, and Medicare paid $3.3M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-01-12.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 19,600 | 23 | $2.29 | $45K |
| J1437 Injection, ferric derisomaltose, 10 mg | Office | 7,700 | 59 | $15.64 | $120K |
| J0897 Injection, denosumab, 1 mg | Office | 5,040 | 29 | $20.40 | $103K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,813 | 31 | $0.09 | $338 |
| J0885 Injection, epoetin alfa, (for non-esrd use), 1000 units | Office | 2,180 | 11 | $6.39 | $14K |
| 36415 Venipuncture Blood Collection | Office | 1,889 | 398 | $8.60 | $16K |
| 85025 Blood Count | Office | 1,857 | 384 | $7.55 | $14K |
| J2405 Injection, ondansetron hydrochloride, per 1 mg | Office | 1,640 | 11 | $0.07 | $123 |
| J2469 Injection, palonosetron hcl, 25 mcg | Office | 1,440 | 16 | $0.71 | $1,028 |
| 99214 Office E&M - Established | Office | 1,212 | 332 | $90.00 | $109K |
| 96372 Injection Administration | Office | 690 | 99 | $10.20 | $7,038 |
| 96413 Chemotherapy Administration | Office | 472 | 36 | $95.99 | $45K |
| 96375 Injection Administration | Office | 432 | 39 | $11.31 | $4,886 |
| 96367 Intravenous Infusion, Hydration | Office | 327 | 37 | $21.05 | $6,884 |
| M0010 Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services | Office | 323 | 44 | $70.88 | $23K |
By year: 2022 $2.5M for 168,119 services; 2023 $3.8M for 245,071 services; 2024 $3.3M for 183,172 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,889 | 398 | $8.60 | $16K |
| 85025 Blood Count | 1,857 | 384 | $7.55 | $14K |
| 85045 Blood Count | 17 | 17 | $3.91 | $66.47 |
Medicare prescription drug claims, 2024
In 2024, the drug Farn Chan prescribed most often to Medicare patients was Oxycodone Hcl, with 112 prescriptions and refills. In total Farn Chan wrote 1,686 Medicare prescriptions that cost $4.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Oxycodone Hcl Generic | 112 | 112 | 15 | $2,880 |
| Eliquis Apixaban | 83 | 119 | 24 | $69K |
| Anastrozole Generic | 73 | 214 | 26 | $1,423 |
| Prednisone Generic | 66 | 74 | 19 | $302 |
| Gabapentin Generic | 57 | 61 | 14 | $643 |
| Pantoprazole Sodium Generic | 55 | 145 | 19 | $985 |
| Xarelto Rivaroxaban | 53 | 119 | 19 | $66K |
| Levothyroxine Sodium Generic | 53 | 125 | 16 | $504 |
| Ondansetron Hcl Generic | 51 | 59 | 27 | $1,428 |
| Pomalyst Pomalidomide | 41 | 41 | Under 11 | $816K |
| Warfarin Sodium Generic | 35 | 81 | Under 11 | $195 |
| Potassium Chloride Generic | 31 | 57 | 11 | $297 |
| Hydroxyurea Generic | 29 | 68 | Under 11 | $778 |
| Zolpidem Tartrate Generic | 28 | 28 | Under 11 | $187 |
| Promacta Eltrombopag Olamine | 27 | 27 | Under 11 | $210K |
Brand drugs: 551 claims; generic drugs: 1,135 claims; opioid claims: 167.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farn Chan $5,211 ($5,211 in general payments such as food, travel and fees) from 59 companies. The largest payer was Janssen Biotech, Inc. with $480.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 15 | $480 |
| Novartis Pharmaceuticals Corporation NVS | 14 | $335 |
| Celgene Corporation BMY | 4 | $248 |
| AstraZeneca Pharmaceuticals LP AZN | 9 | $233 |
| Pfizer Inc. PFE | 9 | $213 |
| BeOne Medicines USA, Inc. ONC | 8 | $204 |
| Merck Sharp & Dohme LLC MRK | 8 | $187 |
| Abbvie Inc. ABBV | 6 | $173 |
| Daiichi Sankyo Inc. 4568.T | 8 | $170 |
| Incyte Corporation INCY | 6 | $154 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.